Search by Drug Name or NDC
NDC 70510-2321-02 RADICAVA ORS Details
RADICAVA ORS
RADICAVA ORS is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mitsubishi Tanabe Pharma America, Inc.. The primary component is .
MedlinePlus Drug Summary
Edaravone is used to treat amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease; a condition in which the nerves that control muscle movement slowly die, causing the muscles to shrink and weaken). Edaravone is in a class of medications called antioxidants. It may work to slow the nerve damage associated with the worsening of ALS symptoms.
Related Packages: 70510-2321-02Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Edaravone Oral
Product Information
| NDC | 70510-2321 |
|---|---|
| Product ID | 70510-2321_d3d515d2-5301-4038-9eff-558de3b0e48d |
| Associated GPIs | 74509030001820 |
| GCN Sequence Number | 083378 |
| GCN Sequence Number Description | edaravone ORAL SUSP 105 MG/5ML ORAL |
| HIC3 | H6I |
| HIC3 Description | AMYOTROPHIC LATERAL SCLEROSIS AGENTS |
| GCN | 52318 |
| HICL Sequence Number | 044252 |
| HICL Sequence Number Description | EDARAVONE |
| Brand/Generic | Brand |
| Proprietary Name | RADICAVA ORS |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | EDARAVONE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | KIT |
| Route | n/a |
| Active Ingredient Strength | n/a |
| Active Ingredient Units | n/a |
| Substance Name | n/a |
| Labeler Name | Mitsubishi Tanabe Pharma America, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA215446 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70510-2321-02 (70510232102)
| NDC Package Code | 70510-2321-2 |
|---|---|
| Billing NDC | 70510232102 |
| Package | 2 CARTON in 1 CARTON (70510-2321-2) / 1 KIT in 1 CARTON (70510-2321-1) * 1 BOTTLE in 1 KIT (70510-2323-1) / 35 mL in 1 BOTTLE |
| Marketing Start Date | 2022-05-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |